The Correlation Between the Frontal Electromyography Parameter in Patient State Index (PSI) Monitor and Train of Four

April 7, 2021 updated by: Hakan Gokalp TAS, Erzincan University

Correlation of Train Of Four (TOF) With Frontal EMG Parameter Measured by Patient State Index (PSI) Monitor in Extubation Phase of General Anesthesia

The Train Of Four (TOF) Monitor will be placed on ulnar nerve on right wrist of the patients who has surgery under general anaesthesia. This is for stimulation of adductor pollicis muscle. Sedline (Masimo Electromyography(EMG) and Patient State Index(PSI)) Monitor will be placed on the frontal area of head. After the induction of general anaesthesia the investigators will wait for disappearance of eyelash reflex. TOF monitor will be calibrated and muscle relaxant will be applied. After TOF is %0 and disappearance of thumb movement the patient will be intubated. After surgery the investigators will apply muscle relaxant reversal drugs. Then the investigators will record PSI and EMG parameters when TOF is %0, %25, %50,%75,%90. When TOF is %90 the investigators will extubate the patient. The investigators will record PSI and EMG parameters after 5 minutes.

Study Overview

Status

Completed

Conditions

Detailed Description

The study is planned prospective and observational. The study started after approval of Erzincan Binali Yıldırım University Ethics Committee and taking written approval of patients. The study includes 84 patients who has surgery continues more then 1 hour, who is between ages 18-65, who is ASA I,II and III. The patients who has allergical reactions of the drugs used, neurological or neuromuscular diseases,the patients who use drugs effecting the neuromuscular junction, pregnant patients, electrolyte disregulations, major organ failures, liver failure, kidney failure, obese and cachectic patients are excluded from the study.

All patients will be informed and signed written approval 1 day before the surgery. Patients will be taken to the operating room, venous catheter will be applied on antecubital area. 3 channel EKG , SpO2 Monitor and noninvasive blood pressure monitorisation will be applied. The patients will be taken 2-4 litres of O2 with nasal cannula .The Train Of Four (TOF) Monitor will be placed on ulnar nerve on right wrist of the patients who has surgery under general anaesthesia. This is for stimulation of adductor pollicis muscle. Sedline (Masimo Electromyography(EMG) and Patient State Index(PSI)) Monitor will be placed on the frontal area of head. After the induction of general anaesthesia the investigators will wait for disappearance of eyelash reflex. TOF monitor will be calibrated and muscle relaxant will be applied. After TOF is %0 and disappearance of thumb movement the patient will be intubated. After surgery the investigators will apply muscle relaxant reversal drugs. PSI and EMG parameters will be recorded when TOF is %0, %25, %50,%75,%90. When TOF is %90 the investigators will extubate the patient. PSI and EMG parameters will be recorded after 5 minutes. The patient will be taken to the PACU room. On 5,10,30 minutes after surgery, the investigators will record aldrete score of patients.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Erzincan, Merkez, Turkey, 24000
        • Erzincan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

the patients wha has surgery continues more then 1 hour

Description

Inclusion Criteria:

  • surgery continues more then 1 hour
  • between ages 18-65
  • ASA I,II and III patients

Exclusion Criteria:

  • The patients who has allergical reactions of the drugs used
  • neurological or neuromuscular diseases
  • the patients who use drugs effecting the neuromuscular junction
  • pregnant patients
  • electrolyte disregulations
  • major organ failures, liver failure, kidney failure
  • obese and cachectic patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient State Index
Time Frame: 0 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
0 minutes
Patient State Index
Time Frame: 1 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
1 minutes
Patient State Index
Time Frame: 2 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
2 minutes
Patient State Index
Time Frame: 3 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
3 minutes
Patient State Index
Time Frame: 4 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
4 minutes
Patient State Index
Time Frame: 5 minutes
Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs
5 minutes
Electromyography (Frontal EMG)
Time Frame: 0 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
0 minutes
Electromyography (Frontal EMG)
Time Frame: 1 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
1 minutes
Electromyography (Frontal EMG)
Time Frame: 2 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
2 minutes
Electromyography (Frontal EMG)
Time Frame: 3 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
3 minutes
Electromyography (Frontal EMG)
Time Frame: 4 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
4 minutes
Electromyography (Frontal EMG)
Time Frame: 5 minutes
Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hakan G. Taş, Mengucek Gazi Education and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2019

Primary Completion (ACTUAL)

March 1, 2020

Study Completion (ACTUAL)

August 1, 2020

Study Registration Dates

First Submitted

April 18, 2019

First Submitted That Met QC Criteria

April 22, 2019

First Posted (ACTUAL)

April 24, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 9, 2021

Last Update Submitted That Met QC Criteria

April 7, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • ErzincanUnv

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Relaxation

Clinical Trials on Masimo Sedline Monitor Patient State Index

Subscribe